Eucommia ulmoides extract and soy isoflavones attenuate postmenopausal osteoporosis by modulating bone-specific transcription factors and inflammatory signaling pathways.

Although individual treatments resulted in modest increases in viability (approximately 105%–120%), the combined treatment raised viability to nearly 150%, representing a highly significant synergistic enhancement ( p < 0.001).

also in 132,142 other papers